Nakayama, I., Ryu, M., Lim, S. H., Kim, J. G., Omori, T., Oh, S. C., Kim, J. Y., Rha, S. Y., Lee, K., Machida, N., Sym, S. J., Narita, Y., Park, Y., Hara, H., Hosaka, H., Kang, B., Kim, I., Bai, L., Hirashima, Y., Hagihara, S., Yamamoto, T., Shitara, K. (2026). EP4 Antagonist ONO-4578 Plus Nivolumab and Chemotherapy in HER2-Negative Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-01072